SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea
· Delayed Price · Currency is KRW
134,000
-2,300 (-1.69%)
At close: Dec 5, 2025
SK Biopharmaceuticals Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 10,493,976 | 8,700,602 | 7,862,650 | 5,646,385 | 7,612,048 | 13,234,939 | |
| Market Cap Growth | 19.64% | 10.66% | 39.25% | -25.82% | -42.48% | - | |
| Enterprise Value | 10,303,841 | 8,637,734 | 7,807,605 | 5,442,304 | 7,267,516 | 12,840,764 | |
| Last Close Price | 134000.00 | 111100.00 | 100400.00 | 72100.00 | 97200.00 | 169000.00 | |
| PE Ratio | 32.75 | 36.14 | - | - | 117.39 | - | |
| Forward PE | 42.29 | 73.81 | - | - | - | - | |
| PS Ratio | 15.54 | 15.89 | 22.16 | 22.94 | 18.18 | 509.06 | |
| PB Ratio | 15.22 | 15.16 | 24.50 | 17.84 | 17.14 | 34.92 | |
| P/TBV Ratio | 15.78 | 16.24 | 29.59 | 18.86 | 17.90 | 36.83 | |
| P/FCF Ratio | 73.36 | 93.05 | - | - | - | - | |
| P/OCF Ratio | 71.79 | 91.68 | - | - | - | - | |
| EV/Sales Ratio | 15.26 | 15.77 | 22.00 | 22.11 | 17.36 | 493.89 | |
| EV/EBITDA Ratio | 58.70 | 75.93 | - | - | 68.18 | - | |
| EV/EBIT Ratio | 65.18 | 89.66 | - | - | 76.53 | - | |
| EV/FCF Ratio | 72.03 | 92.38 | - | - | - | - | |
| Debt / Equity Ratio | 0.07 | 0.32 | 0.56 | 0.49 | 0.04 | 0.05 | |
| Debt / EBITDA Ratio | 0.23 | 1.62 | - | - | 0.15 | - | |
| Debt / FCF Ratio | 0.35 | 1.97 | - | - | - | - | |
| Asset Turnover | 0.75 | 0.62 | 0.51 | 0.38 | 0.73 | 0.08 | |
| Inventory Turnover | 0.31 | 0.40 | 0.35 | 0.53 | 0.60 | 0.13 | |
| Quick Ratio | 1.84 | 1.26 | 1.47 | 2.28 | 2.64 | 5.67 | |
| Current Ratio | 2.43 | 1.64 | 2.02 | 2.99 | 3.18 | 6.16 | |
| Return on Equity (ROE) | 58.15% | 50.72% | -11.10% | -36.66% | 15.75% | -135.18% | |
| Return on Assets (ROA) | 13.73% | 6.84% | -3.38% | -12.53% | 10.38% | -46.83% | |
| Return on Capital (ROIC) | 19.35% | 9.58% | -4.83% | -17.57% | 13.84% | -60.65% | |
| Return on Capital Employed (ROCE) | 25.90% | 15.00% | -7.80% | -26.20% | 19.20% | -55.70% | |
| Earnings Yield | 3.05% | 2.77% | -0.42% | -2.47% | 0.85% | -1.87% | |
| FCF Yield | 1.36% | 1.07% | -1.23% | -2.92% | -1.28% | -1.68% | |
| Buyback Yield / Dilution | - | - | - | - | -9.12% | -10.41% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.